Acadia pharmaceuticals to present at upcoming investor conferences

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that it will participate at the following upcoming investor conferences: bofa securities 2022 healthcare conference fireside chat: tuesday, may 10, 2022 at 3:20 p.m. pacific time in las vegas, nv 2022 rbc capital markets global healthcare conference fireside chat: wednesday, may 18, 2022 at 4:05 p.m. eastern time in new york, ny live webcasts of the presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation. about acadia pharmaceuticals acadia is advancing breakthroughs in neuroscience to elevate life. for more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. we developed and commercialized the first and only approved therapy for hallucinations and delusions associated with parkinson’s disease psychosis. our late-stage development efforts are focused on treating psychosis in patients with dementia, the negative symptoms of schizophrenia and rett syndrome. our early-stage development efforts are focused on novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. for more information, visit us at www.acadia-pharm.com and follow us on linkedin and twitter.
ACAD Ratings Summary
ACAD Quant Ranking